Cost-effectiveness of the polymerase chain reaction versus smear examination for the diagnosis of tuberculosis in kenya: A theoretical model

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 3, 1998, Pages 235-241

  Roos, B R ^a   Van Cleeff, M R A ^a   Githui, W A ^b   Kivihya Ndugga, L ^b   Odhiambo, J A ^b   Kibuga, D K ^c   Klatser, P R ^a  

^a ROYAL TROPICAL INSTITUTE   (Netherlands)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c MINISTRY OF HEALTH   (Kenya)

Author keywords

Cost effectiveness; Diagnosis; PCR; Tuberculosis

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; KENYA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPUTUM SMEAR; THEORETICAL STUDY; TUBERCULOSIS;

BACTERIOLOGICAL TECHNIQUES; COST-BENEFIT ANALYSIS; HUMANS; KENYA; MODELS, THEORETICAL; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 0031952445     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ministry of Health, Kenya. Health Information System: 1994. Nairobi, Kenya.
2. National Leprosy and Tuberculosis Project. 1995; Development Plan 1-1-1996/31-12-2000. Ministry of Health, Nairobi, Kenya.
3. Caranzaro A, Davidson B L, Fujiwara P I, et al. Cost-effectiveness of direct amplification tests for pulmonary tuberculosis. Proceedings of the American Thoracic Society Workshop, 'Rapid Diagnostic Tests for Tuberculosis. What is the appropriate use?' 1996.
4. Greenbaum M, Beyt B E, Murray P R. The accuracy of diagnosing pulmonary tuberculosis at a teaching hospital. Am Rev Respir Dis 1980; 121: 477-481.
5. Stratton C W. Tuberculosis, infection control and the microbiology laboratory. Infect Control Hosp Epidemiol 1993; 14: 481-487.
6. Chin D P, Yajko W, Hadley W K, et al. Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens. Am J Respir Crit Care Med 1995; 151: 1872-1877.
7. National Leprosy and Tuberculosis Project. Manual for NLTP staff. Nairobi, Kenya: Ministry of Health, 1995.
8. Carpentier E, Drouillard B, Dailloux M, et al. Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis Test: a multicenter study. J Clin Microbiol 1995; 33: 3106-3110.
9. Moore D F, Curry J L Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplicor PCR. J Clin Microbiol 1995; 33: 2686-2691.
10. Stauffer F, Mutchlechner R, Hasenberger P, Stadibauer S, Schinko H. Detection of Mycobacterium tuberculosis complex in clinical specimens by a commercial polymerase chain reaction kit. Eur J Clin Microbiol Infect Dis 1995; 14: 1046-1051.
11. Tevere V, Appleman M D, Bankowski M, et al. Results of multicenter clinical trial study for the direct detection of Mycobacterium tuberculosis in respiratory samples utilizing the Amplicor Mycobacterium tuberculosis Test. Abstract. 16th Annual Meeting of the European Society for Mycobacteriology 1995: Pisa, Italy.
12. Conly J, Krajden S, Krajden M, Bannatyne R, Wobeser W, and the Toronto Rapid Diagnostics Consortium. Conventional vs. rapid molecular diagnostic strategies for M. tuberculosis (M.tb.): a cost-effectiveness analysis (CEA). Abstract D93. In: Programs and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, DC 1995: 83.
13. Fraser I S, Wilkins E G L. PCR in the diagnosis of pulmonary tuberculosis: a clinical and economic evaluation. Abstract D94. In: Programs and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology., Washington, DC 1995: 83.
14. Perry S, Ganiats T G, Leveque J, Catanzaro A. Cost-effectiveness of the Direct Amplified Test for TB. Abstract of the 1996 Annual Meeting of the International Union Against Tuberculosis and Lung Disease, 1996; Paris, France.
15. Doern G V. Diagnostic mycobacteriology: where are we today? J Clin Microbiol 1996; 34: 1873-1876.
16. Collen M, Goodman C. Cost-effectiveness and cost-benefit analyses. In: Assessing medical technologies. Washington: Institute of Medicine, National Academy Press, 1985: 136-144.
17. International Dispensary Association. Price Indicator 1996. Amsterdam.
18. Bergmann, J S, Woods, G L. Clinical evaluation of the Roche Amplicor PCR Mycobacterium tuberculosis Test for detection of M. tuberculosis in respiratory specimens. J Clin Microbiol 1996; 35: 1083-1085.
19. Devallois A, Legrand E, Rastogi N. Evaluation of Amplicor MTB Test as adjunct to smears and culture for direct detection of Mycobacterium tuberculosis in the French Caribbean. J Clin Microbiol 1996; 34: 1065-1068.
20. Wilson S M, McNerney R M, Nye P M, Godfrey-Faussett P D, Stoker N G, Voller A. Progress toward a simplified Polymerase Chain Reaction and its application to tuberculosis. J Clin Microbiol 1993; 31: 776-782.
21. Murray C J L, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65(1): 6-26.
22. Ipuge Y A I, Rieder H L, Enarson D A. The yield of acid-fast bacilli from serial smears in routine microscopy laboratories in rural Tanzania. Trans Roy Soc Trop Med Hyg 1996; 90: 258-261.
23. Bosman, M C J. Tuberculosebestrijding in Kenya, Tegen de tuberculose 1993; 89: 98-102.
24. Ichiyama S, Iinuma Y, Tawada Y, et al. Evaluation of Gen-Probe Amplified Mycobacterium tuberculosis Direct Test and Roche PCR-microwell plate hybridization method (Amplicor Mycobacterium) for direct detection of mycobacteria. J Clin Microbiol 1996; 34: 130-133.